• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.73% Nasdaq Up 0.60%

    Agenus Inc. (AGEN)

    -NasdaqCM
    3.92 Down 0.10(2.49%) Mar 28, 4:00PM EDT
    Prev Close:4.02
    Open:4.02
    Bid:3.70 x 300
    Ask:5.35 x 100
    1y Target Est:5.92
    Beta:2.58971
    Earnings Date:Apr 26 - May 1 (Est.)
    Day's Range:3.89 - 4.08
    52wk Range:2.97 - 7.49
    Volume:764,444
    Avg Vol (3m):1,191,280
    Market Cap:385.45M
    P/E (ttm):N/A
    EPS (ttm):-1.46
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AGENDown 2.49%385.45M
    ABPI 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :-1.22
    Quarterly EPS Est (Mar-17) :-0.28
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agenus Inc., a clinical-stage immuno-oncology company, focuses on the discovery and development of therapies that engage the body’s immune system for patients suffering with cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback